Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Fabienne Mizzi"'
Autor:
Akihiko Ikoma, Toshiya Ebata, Laurent Chantalat, Kimitoshi Takemura, Fabienne Mizzi, Michel Poncet, Didier LeClercq
Publikováno v:
Acta Dermato-Venereologica, Vol 99, Iss 3, Pp 268-273 (2018)
Three clinical studies were conducted to test a newly-developed app for smartwatches, which included an algorithm to measure nocturnal scratching using acceleration data. The first study in 5 patients with atopic dermatitis demonstrated high reliabil
Externí odkaz:
https://doaj.org/article/f6a8e29bc0fd458a9d9da38c986214dc
Autor:
Michel Poncet, Toshiya Ebata, Akihiko Ikoma, Laurent Chantalat, Kimitoshi Takemura, Fabienne Mizzi, Didier LeClercq
Publikováno v:
Acta Dermato-Venereologica, Vol 99, Iss 3, Pp 268-273 (2018)
Three clinical studies were conducted to test a newly-developed app for smartwatches, which included an algorithm to measure nocturnal scratching using acceleration data. The first study in 5 patients with atopic dermatitis demonstrated high reliabil
Autor:
Fabienne Mizzi, Jonathan Barker, Andrew Yule Finlay, Christopher E.M. Griffiths, Colin Fleming, Stéphanie Arsonnaud
Publikováno v:
Journal of Dermatological Treatment. 17:90-95
The clinical benefit of currently available tar blend shampoos for the treatment of scalp psoriasis is restricted due to their limited efficacy, low cosmetic appeal and potential for carcinogenicity. This 4-week multicentre, randomized, parallel-grou
Autor:
Louis, Dubertret, Mohsen, Alirezai, Gilles, Rostain, Morad, Lahfa, Dan, Forsea, Bogdan Dimitrie, Niculae, Margit, Simola, Attila, Horvath, Fabienne, Mizzi
Publikováno v:
European journal of dermatology : EJD. 13(1)
We compared the efficacy and safety of lymecycline 300 mg od vs lymecycline 150 mg bid or placebo in the treatment of moderate to severe acne. 271 patients received either oral lymecycline 300 mg od + placebo od, lymecycline 150 mg bid, or placebo bi
Publikováno v:
Cutis. 70(4)
Acne vulgaris is the most common dermatologic disorder seen in American black patients (ie, African Americans and African Caribbeans, Fitzgerald skin types IV through VI). Despite its prevalence, there is a lack of data on the effects of treatments,